Liquidia – $53 Million IPO

Washington, DC – August 21, 2018 – Cooley advised the underwriters on Liquidia Technologies’ $53.2 million initial public offering of 4,833,099 shares of common stock, which included 287,644 shares issued upon the underwriters’ partial exercise of their option to purchase additional shares to cover over-allotments. Partners Brent Siler, Brian Leaf and Div Gupta led the Cooley team advising the underwriters. 

Jefferies and Cowen acted as the lead book-running managers for the offering. Needham & Company and Wedbush PacGrow acted as co-managers for the offering.

Liquidia Technologies, which now trades on the Nasdaq Capital Market as “LQDA,” is a late-stage clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients.

About Cooley LLP

Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law. 

Cooley has 900+ lawyers across 13 offices in the United States, China and Europe.

Related Contacts
Brent Siler  Senior Counsel Washington, DC, Reston
Brian Leaf  Partner Reston
Div Gupta  Partner New York
Madison Jones  Partner Washington, DC
Natasha Leskovsek  Of Counsel Washington, DC
Phil Mitchell  Partner New York
Bill Christiansen  Partner Seattle
Jeffery Wyzykowski  Patent Agent Washington, DC
Stephanie Gentile  Partner New York
Francis Wheeler  Partner Colorado